Christopher Lo is a Senior Associate at Enavate Sciences. As a member of the investment team, he focuses on prospecting and due diligence, as well as supporting our partner companies to accelerate innovation. Prior to this, he worked at Roivant Sciences, evaluating investments, and developing novel medicines. He also contributed to the clinical development of gene therapies for rare diseases at Aruvant Sciences. Chris currently serves as a board observer on Enavate Sciences portfolio company, Normunity.

Chris graduated from the Jerome Fisher Program in Management & Technology, receiving a B.A.S. in Bioengineering from the University of Pennsylvania and a B.S. in Economics and Statistics from Wharton.

Return to Team